Publications
25
Citations
769
Est. group size
~15
Recurring co-author estimate
Active years
10
Publishing since 2017
- Germline-targeting HIV immunogen induces cross-neutralizing antibodies in outbred macaques
Immunity · 2026
- Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift
Cell Reports · 2025
- Intranasal measles virus- and mumps virus-based SARS-CoV-2 vaccine candidates prevent SARS-CoV-2 infection and transmission.
PubMed · 2025
- Bisulfite Sequencing to Map 5-Methylcytosine Sites in Human Respiratory Syncytial Virus RNA
Methods in molecular biology · 2025
- Directed evolution of a stem-helix–targeting antibody enables MERS-CoV cross-neutralization through enhanced binding affinity
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- KARR-seq reveals cellular higher-order RNA structures and RNA–RNA interactions
Nature Biotechnology · 2024
- Recombinant measles virus expressing prefusion spike protein stabilized by six rather than two prolines is more efficacious against SARS‐CoV‐2 infection
Journal of Medical Virology · 2023
- Abstract 2659: 5-methylcytosine (m5C) RNA modification controls the innate immune response to virus infection by regulating type I interferons
Journal of Biological Chemistry · 2023
- 5-methylcytosine (m <sup>5</sup> C) RNA modification controls the innate immune response to virus infection by regulating type I interferons
Proceedings of the National Academy of Sciences · 2022
- SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern
Proceedings of the National Academy of Sciences · 2022
- A highly efficacious live attenuated mumps virus–based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike
Proceedings of the National Academy of Sciences · 2022
- Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19
Journal of Virology · 2022
- 5-methylcytosine (m5C) RNA modification controls the innate immune response to virus infection by regulating type I interferons
Open MIND · 2022
- 5-methylcytosine (m5C) RNA modification controls the innate immune response to virus infection by regulating type I interferons
University of Chicago · 2022
- Nonsegmented Negative-Sense RNA Viruses Utilize <i>N</i> <sup>6</sup> -Methyladenosine (m <sup>6</sup> A) as a Common Strategy To Evade Host Innate Immunity
Journal of Virology · 2021
- Journal of Virology×6
- Proceedings of the National Academy of Sciences×5
- Bioconjugate Chemistry×1
- Nature Biotechnology×1
- PLoS Pathogens×1
- Mahesh KC
Medicine · The Ohio State University
- Sarah Karow
Medicine · The Ohio State University
- Hadi M. Yassine
Medicine · Indiana University
- Cong Zeng
Medicine · The Ohio State University
- Andrew D. Mesecar
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile